Product NDC: | 55648-947 |
Proprietary Name: | CEFOTAXIME |
Non Proprietary Name: | CEFOTAXIME |
Active Ingredient(s): | 500 mg/mL & nbsp; CEFOTAXIME |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
Dosage Form(s): | INJECTION, POWDER, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 55648-947 |
Labeler Name: | WOCKHARDT LIMITED |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA065197 |
Marketing Category: | ANDA |
Start Marketing Date: | 20080620 |
Package NDC: | 55648-947-02 |
Package Description: | 10 CARTON in 1 CARTON (55648-947-02) > 1 VIAL, SINGLE-DOSE in 1 CARTON (55648-947-01) > 10 mL in 1 VIAL, SINGLE-DOSE |
NDC Code | 55648-947-02 |
Proprietary Name | CEFOTAXIME |
Package Description | 10 CARTON in 1 CARTON (55648-947-02) > 1 VIAL, SINGLE-DOSE in 1 CARTON (55648-947-01) > 10 mL in 1 VIAL, SINGLE-DOSE |
Product NDC | 55648-947 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | CEFOTAXIME |
Dosage Form Name | INJECTION, POWDER, FOR SOLUTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS |
Start Marketing Date | 20080620 |
Marketing Category Name | ANDA |
Labeler Name | WOCKHARDT LIMITED |
Substance Name | CEFOTAXIME SODIUM |
Strength Number | 500 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Cephalosporin Antibacterial [EPC],Cephalosporins [Chemical/Ingredient] |